Molecular basis of fibrinogen naples associated with defective thrombin binding and thrombophilia. Homozygous substitution of Bβ 68 Ala → Thr

J. Koopman, F. Haverkate, S. T. Lord, J. Grimbergen, P. M. Mannucci

Research output: Contribution to journalArticle

59 Citations (Scopus)

Abstract

In an abnormal fibrinogen (fibrinogen Naples) associated with congenital thrombophilia we have identified a single base substitution (G → A) in the Bβ chain gene that results in an amino acid substitution of alanine by threonine at position 68 in the Bβ chain of fibrinogen. The propositus and two siblings were found to be homozygous for the mutation, whereas the parents and another sibling were found to be heterozygous. Individuals homozygous for the defect had a severe history of both arterial and venous thrombosis; heterozygous individuals had no clinical symptoms. The three homozygotes had a prolonged thrombin clotting time in plasma, whereas the heterozygotes had a normal thrombin clotting time. Fibrinopeptide A and B (FpA and FpB) release from purified fibrinogen by human α-thrombin was delayed in both the homozygous propositus and a heterozygous family member. Release of FpA from the normal and abnormal amino-terminal disulfide knot (NDSK) corresponded to that found with the intact fibrinogens, indicating a decreased interaction of thrombin with the NDSK part of fibrinogen Naples. Binding studies showed that fibrin from homozygous abnormal fibrinogen bound <10% of active site inhibited α-thrombin as compared with normal fibrin, while fibrin formed from heterozygous abnormal fibrinogen bound ~ 50% of α- thrombin. These results suggest that the mutation of Bβ Ala 68 → Thr affects the binding of α-thrombin to fibrin, and that defective binding results in a decreased release of FpA and FpB in both homozygous and heterozygous abnormal fibrinogens.

Original languageEnglish
Pages (from-to)238-244
Number of pages7
JournalJournal of Clinical Investigation
Volume90
Issue number1
Publication statusPublished - 1992

Fingerprint

Abnormal Fibrinogens
Thrombophilia
Thrombin
Fibrin
Fibrinogen
Thrombin Time
Siblings
Fibrinopeptide B
Fibrinopeptide A
Mutation
Homozygote
Threonine
Amino Acid Substitution
Heterozygote
Venous Thrombosis
Alanine
Catalytic Domain
Parents
fibrinogen Milano II
Genes

Keywords

  • α-thrombin binding
  • amino-terminal disulfide knot
  • dysfibrinogenemia
  • fibrinopeptide release
  • polymerase chain reaction

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Molecular basis of fibrinogen naples associated with defective thrombin binding and thrombophilia. Homozygous substitution of Bβ 68 Ala → Thr. / Koopman, J.; Haverkate, F.; Lord, S. T.; Grimbergen, J.; Mannucci, P. M.

In: Journal of Clinical Investigation, Vol. 90, No. 1, 1992, p. 238-244.

Research output: Contribution to journalArticle

@article{6ce982dec7df4275ba6ed88e3db70ffb,
title = "Molecular basis of fibrinogen naples associated with defective thrombin binding and thrombophilia. Homozygous substitution of Bβ 68 Ala → Thr",
abstract = "In an abnormal fibrinogen (fibrinogen Naples) associated with congenital thrombophilia we have identified a single base substitution (G → A) in the Bβ chain gene that results in an amino acid substitution of alanine by threonine at position 68 in the Bβ chain of fibrinogen. The propositus and two siblings were found to be homozygous for the mutation, whereas the parents and another sibling were found to be heterozygous. Individuals homozygous for the defect had a severe history of both arterial and venous thrombosis; heterozygous individuals had no clinical symptoms. The three homozygotes had a prolonged thrombin clotting time in plasma, whereas the heterozygotes had a normal thrombin clotting time. Fibrinopeptide A and B (FpA and FpB) release from purified fibrinogen by human α-thrombin was delayed in both the homozygous propositus and a heterozygous family member. Release of FpA from the normal and abnormal amino-terminal disulfide knot (NDSK) corresponded to that found with the intact fibrinogens, indicating a decreased interaction of thrombin with the NDSK part of fibrinogen Naples. Binding studies showed that fibrin from homozygous abnormal fibrinogen bound <10{\%} of active site inhibited α-thrombin as compared with normal fibrin, while fibrin formed from heterozygous abnormal fibrinogen bound ~ 50{\%} of α- thrombin. These results suggest that the mutation of Bβ Ala 68 → Thr affects the binding of α-thrombin to fibrin, and that defective binding results in a decreased release of FpA and FpB in both homozygous and heterozygous abnormal fibrinogens.",
keywords = "α-thrombin binding, amino-terminal disulfide knot, dysfibrinogenemia, fibrinopeptide release, polymerase chain reaction",
author = "J. Koopman and F. Haverkate and Lord, {S. T.} and J. Grimbergen and Mannucci, {P. M.}",
year = "1992",
language = "English",
volume = "90",
pages = "238--244",
journal = "Journal of Clinical Investigation",
issn = "0021-9738",
publisher = "The American Society for Clinical Investigation",
number = "1",

}

TY - JOUR

T1 - Molecular basis of fibrinogen naples associated with defective thrombin binding and thrombophilia. Homozygous substitution of Bβ 68 Ala → Thr

AU - Koopman, J.

AU - Haverkate, F.

AU - Lord, S. T.

AU - Grimbergen, J.

AU - Mannucci, P. M.

PY - 1992

Y1 - 1992

N2 - In an abnormal fibrinogen (fibrinogen Naples) associated with congenital thrombophilia we have identified a single base substitution (G → A) in the Bβ chain gene that results in an amino acid substitution of alanine by threonine at position 68 in the Bβ chain of fibrinogen. The propositus and two siblings were found to be homozygous for the mutation, whereas the parents and another sibling were found to be heterozygous. Individuals homozygous for the defect had a severe history of both arterial and venous thrombosis; heterozygous individuals had no clinical symptoms. The three homozygotes had a prolonged thrombin clotting time in plasma, whereas the heterozygotes had a normal thrombin clotting time. Fibrinopeptide A and B (FpA and FpB) release from purified fibrinogen by human α-thrombin was delayed in both the homozygous propositus and a heterozygous family member. Release of FpA from the normal and abnormal amino-terminal disulfide knot (NDSK) corresponded to that found with the intact fibrinogens, indicating a decreased interaction of thrombin with the NDSK part of fibrinogen Naples. Binding studies showed that fibrin from homozygous abnormal fibrinogen bound <10% of active site inhibited α-thrombin as compared with normal fibrin, while fibrin formed from heterozygous abnormal fibrinogen bound ~ 50% of α- thrombin. These results suggest that the mutation of Bβ Ala 68 → Thr affects the binding of α-thrombin to fibrin, and that defective binding results in a decreased release of FpA and FpB in both homozygous and heterozygous abnormal fibrinogens.

AB - In an abnormal fibrinogen (fibrinogen Naples) associated with congenital thrombophilia we have identified a single base substitution (G → A) in the Bβ chain gene that results in an amino acid substitution of alanine by threonine at position 68 in the Bβ chain of fibrinogen. The propositus and two siblings were found to be homozygous for the mutation, whereas the parents and another sibling were found to be heterozygous. Individuals homozygous for the defect had a severe history of both arterial and venous thrombosis; heterozygous individuals had no clinical symptoms. The three homozygotes had a prolonged thrombin clotting time in plasma, whereas the heterozygotes had a normal thrombin clotting time. Fibrinopeptide A and B (FpA and FpB) release from purified fibrinogen by human α-thrombin was delayed in both the homozygous propositus and a heterozygous family member. Release of FpA from the normal and abnormal amino-terminal disulfide knot (NDSK) corresponded to that found with the intact fibrinogens, indicating a decreased interaction of thrombin with the NDSK part of fibrinogen Naples. Binding studies showed that fibrin from homozygous abnormal fibrinogen bound <10% of active site inhibited α-thrombin as compared with normal fibrin, while fibrin formed from heterozygous abnormal fibrinogen bound ~ 50% of α- thrombin. These results suggest that the mutation of Bβ Ala 68 → Thr affects the binding of α-thrombin to fibrin, and that defective binding results in a decreased release of FpA and FpB in both homozygous and heterozygous abnormal fibrinogens.

KW - α-thrombin binding

KW - amino-terminal disulfide knot

KW - dysfibrinogenemia

KW - fibrinopeptide release

KW - polymerase chain reaction

UR - http://www.scopus.com/inward/record.url?scp=0026769907&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026769907&partnerID=8YFLogxK

M3 - Article

VL - 90

SP - 238

EP - 244

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

SN - 0021-9738

IS - 1

ER -